phase readout
saveNCT06648434: MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Washington University School of Medicine. Phase: PHASE1. Conditions: Metastatic Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Cancer of the Pancreas
view source ↗
comments(0)
5-min edit window · permanent after that